Nanobac Pharmaceuticals, Inc. Announces Results Of Pre-IND Meeting With FDA
TAMPA, Fla.--(BUSINESS WIRE)--Nanobac Pharmaceuticals, Inc. (OTCBB:NNBP) "Nanobac" or "the Company" announces the results of a Pre-IND meeting with the FDA on January 19, 2007 to discuss specific details of the plan for developing a treatment for patients with chronic prostatitis, referred to as CP/CPPS, and to discuss the content of the initial IND required to support clinical evaluation.